Kendle Invites You to Attend Its Fourth Quarter and Year End 2007 Earnings Conference Call and Webcast

Thursday, January 31, 2008 General News J E 4
Kendle (Nasdaq: KNDL) will conduct a telephone conference call andsimultaneous webcast Feb. 27 at 8:30 a.m. Eastern Time to discuss itsfinancial results for the Fourth Quarter and Year Ended Dec. 31, 2007. Aquestion and answer session will follow.

(Logo: )

Webcast Instructions

To access the live webcast, go to or Instructions for accessingthe webcast are provided at both sites. The webcast will be archived (click on "Investors") shortly after the call for on-demandreplay through 5 p.m. Eastern Time on March 28, 2008. Please note thatwebcast participants will not be able to ask questions.

System requirements for the webcast include Windows Media Player softwareand at least a 28.8 Kbps connection to the Internet. Media Player isdownloadable at no charge from

Conference Call Instructions

To register (RSVP) for the telephone conference call, U.S. and Canadianparticipants should dial (800) 223-7104. Participants outside North Americashould dial (706) 645-6519.

To participate in the telephone conference call, interested parties in theUnited States and Canada should dial (800) 399-0069. Participants outsideNorth America should dial (706) 643-3694. A replay will be available through 5p.m. Eastern Time on March 28 by dialing (706) 645-9291 and enteringconference ID number 32648462

About Kendle

Kendle International Inc. (Nasdaq: KNDL) is among the world's leadingglobal clinical research organizations. We deliver innovative and robustclinical development solutions -- from first-in-human studies through marketlaunch and surveillance -- to help the world's biopharmaceutical companiesmaximize product life cycles and grow market share.

Our global clinical development business is focused on five regions --North America, Europe, Asia/Pacific, Latin America and Africa -- to meetcustomer needs. We have conducted clinical trials and provided regulatory andpharmacovigilance services in more than 80 countries. The company was namedthe "Top CRO to Work With" in the Thomson CenterWatch 2007 Survey of U.S.Investigative Sites.

Additional information and investor kits are available upon request fromKendle, 441 Vine Street, Suite 1200, Cincinnati, OH 45202 or from theCompany's Web site at, Jan. 30 /PRNewswire-FirstCall/ -- CALL DATE: Wednesday, Feb. 27, 2008 TIME: 8:30 a.m. Eastern Time HOST: Dr. Candace Kendle, Chairman and CEO

SOURCE Kendle International Inc.


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Cardinal Health CEO of Clinical & Medical Products...
Ascension Orthopedics Launches the TITAN(TM) Humer...